FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2117620147> ?p ?o ?g. }

• W2117620147 endingPage "745" @default.
• W2117620147 startingPage "741" @default.
• W2117620147 abstract "In the search for a sensitive, accurate, and noninvasive technique for quantifying human tumor hypoxia, our laboratory has synthesized several potential radiodiagnostic agents. The purpose of this study was to assess and compare the hypoxic marking properties of both radioiodinated and Tc-99m labeled markers in appropriate test systems which can predict for in vivo activity.Preclinical assessment of hypoxic marker specificity and sensitivity employed three laboratory assays with tumor cells in vitro and in vivo. Radiolabeled marker uptake and/or binding to whole EMT-6 tumor cells under extremely hypoxic and aerobic conditions was measured and their ratio defined hypoxia-specific factor (HSF). Marker specificity to hypoxic tumor tissue was estimated from its selective avidity to two rodent tumors in vivo, whose radiobiologic hypoxic fractions (HF) had been measured. The ratios of % injected dose/gram (%ID/g) of marker at various times in EMT-6 tumor tissue relative to that in the blood and muscle of scid mice were used to quantify hypoxia-specific activity. This tumor in this host exhibited an average radiobiologic HF of approximately 35%. As well, nuclear medicine images were acquired from R3327-AT (HF approximately =15%) and R3327-H (no measurable HF) prostate carcinomas growing in rats to distinguish between marker avidity due to hypoxia versus perfusion.The HSF for FC-103 and other iodinated markers were higher (5-40) than those for FC-306 and other Tc-99m labeled markers. The latter did not show hypoxia-specific uptake into cells in vitro. Qualitative differences were observed in the biodistribution and clearance kinetics of the iodinated azomycin nucleosides relative to the technetium chelates. The largest tumor/blood (T/B) and tumor/muscle (T/M) ratios were observed for compounds of the azomycin nucleoside class in EMT-6 tumor-bearing scid mice. These markers also showed a 3-4 x higher uptake into R3327-AT tumors relative to the well-perfused R3327-H tumors. While both FC-306 and CERETEC rapidly distributed at unique concentrations to different tissues, their avidity to EMT-6 and R3327-AT tumors did not correlate with tumor HF.The halogenated azomycin nucleosides with the lowest lipid/water partition coefficient values were found to yield the optimal hypoxia-specific signal in these animal tumors. Our Tc-99m-labeled azomycin chelates showed little or no hypoxia-specific uptake and had in vivo biodistribution and clearance kinetics similar to those of CERETEC, a perfusion agent with no known hypoxic binding activity." @default.
• W2117620147 created "2016-06-24" @default.
• W2117620147 creator A5021142392 @default.
• W2117620147 creator A5055725897 @default.
• W2117620147 creator A5062406672 @default.
• W2117620147 creator A5078010922 @default.
• W2117620147 creator A5088256105 @default.
• W2117620147 date "1998-11-01" @default.
• W2117620147 modified "2023-09-27" @default.
• W2117620147 title "Preclinical assessment of hypoxic marker specificity and sensitivity" @default.
• W2117620147 cites W1980675667 @default.
• W2117620147 cites W1994216439 @default.
• W2117620147 cites W1997112823 @default.
• W2117620147 cites W2001007240 @default.
• W2117620147 cites W2006654035 @default.
• W2117620147 cites W2013436421 @default.
• W2117620147 cites W2030593016 @default.
• W2117620147 cites W2054695479 @default.
• W2117620147 cites W2061970343 @default.
• W2117620147 cites W2063040188 @default.
• W2117620147 cites W2082718894 @default.
• W2117620147 cites W2087604644 @default.
• W2117620147 cites W2117562239 @default.
• W2117620147 cites W2118170166 @default.
• W2117620147 cites W2136786497 @default.
• W2117620147 cites W2167229055 @default.
• W2117620147 cites W2322334299 @default.
• W2117620147 cites W2326223910 @default.
• W2117620147 cites W951668 @default.
• W2117620147 doi "https://doi.org/10.1016/s0360-3016(98)00315-0" @default.
• W2117620147 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9845088" @default.
• W2117620147 hasPublicationYear "1998" @default.
• W2117620147 type Work @default.
• W2117620147 sameAs 2117620147 @default.
• W2117620147 citedByCount "14" @default.
• W2117620147 countsByYear W21176201472013 @default.
• W2117620147 crossrefType "journal-article" @default.
• W2117620147 hasAuthorship W2117620147A5021142392 @default.
• W2117620147 hasAuthorship W2117620147A5055725897 @default.
• W2117620147 hasAuthorship W2117620147A5062406672 @default.
• W2117620147 hasAuthorship W2117620147A5078010922 @default.
• W2117620147 hasAuthorship W2117620147A5088256105 @default.
• W2117620147 hasConcept C126322002 @default.
• W2117620147 hasConcept C142724271 @default.
• W2117620147 hasConcept C150903083 @default.
• W2117620147 hasConcept C159654299 @default.
• W2117620147 hasConcept C178790620 @default.
• W2117620147 hasConcept C179223381 @default.
• W2117620147 hasConcept C185592680 @default.
• W2117620147 hasConcept C202751555 @default.
• W2117620147 hasConcept C203014093 @default.
• W2117620147 hasConcept C207001950 @default.
• W2117620147 hasConcept C2777807558 @default.
• W2117620147 hasConcept C2779081379 @default.
• W2117620147 hasConcept C502942594 @default.
• W2117620147 hasConcept C509974204 @default.
• W2117620147 hasConcept C540031477 @default.
• W2117620147 hasConcept C55493867 @default.
• W2117620147 hasConcept C71924100 @default.
• W2117620147 hasConcept C7836513 @default.
• W2117620147 hasConcept C86803240 @default.
• W2117620147 hasConceptScore W2117620147C126322002 @default.
• W2117620147 hasConceptScore W2117620147C142724271 @default.
• W2117620147 hasConceptScore W2117620147C150903083 @default.
• W2117620147 hasConceptScore W2117620147C159654299 @default.
• W2117620147 hasConceptScore W2117620147C178790620 @default.
• W2117620147 hasConceptScore W2117620147C179223381 @default.
• W2117620147 hasConceptScore W2117620147C185592680 @default.
• W2117620147 hasConceptScore W2117620147C202751555 @default.
• W2117620147 hasConceptScore W2117620147C203014093 @default.
• W2117620147 hasConceptScore W2117620147C207001950 @default.
• W2117620147 hasConceptScore W2117620147C2777807558 @default.
• W2117620147 hasConceptScore W2117620147C2779081379 @default.
• W2117620147 hasConceptScore W2117620147C502942594 @default.
• W2117620147 hasConceptScore W2117620147C509974204 @default.
• W2117620147 hasConceptScore W2117620147C540031477 @default.
• W2117620147 hasConceptScore W2117620147C55493867 @default.
• W2117620147 hasConceptScore W2117620147C71924100 @default.
• W2117620147 hasConceptScore W2117620147C7836513 @default.
• W2117620147 hasConceptScore W2117620147C86803240 @default.
• W2117620147 hasIssue "4" @default.
• W2117620147 hasLocation W21176201471 @default.
• W2117620147 hasLocation W21176201472 @default.
• W2117620147 hasOpenAccess W2117620147 @default.
• W2117620147 hasPrimaryLocation W21176201471 @default.
• W2117620147 hasRelatedWork W1966980125 @default.
• W2117620147 hasRelatedWork W1984816716 @default.
• W2117620147 hasRelatedWork W2063348352 @default.
• W2117620147 hasRelatedWork W2068131347 @default.
• W2117620147 hasRelatedWork W2083105637 @default.
• W2117620147 hasRelatedWork W2117620147 @default.
• W2117620147 hasRelatedWork W2356025731 @default.
• W2117620147 hasRelatedWork W2357336689 @default.
• W2117620147 hasRelatedWork W2370010295 @default.
• W2117620147 hasRelatedWork W2468875394 @default.
• W2117620147 hasVolume "42" @default.
• W2117620147 isParatext "false" @default.
• W2117620147 isRetracted "false" @default.

• next